comparemela.com

Latest Breaking News On - Kimd blickenstaff - Page 1 : comparemela.com

Nuvation Bio Inc. (NYSE:NUVB) Director Acquires $499,348.10 in Stock

Nuvation Bio Inc. (NYSE:NUVB – Get Free Report) Director Kim D. Blickenstaff purchased 172,189 shares of the company’s stock in a transaction on Tuesday, June 11th. The stock was purchased at an average cost of $2.90 per share, for a total transaction of $499,348.10. Following the purchase, the director now directly owns 172,189 shares in […]

Canada
Kimd-blickenstaff
Nuvation-bio
Royal-bank
Nuvation-bio-inc
Jacobs-levy-equity-management-inc
Pricet-rowe-associates-inc
Vanguard-group-inc
Jefferies-financial-group
Acadian-asset-management
Get-free-report
Director-kim

Oppenheimer Analysts Cut Earnings Estimates for Tandem Diabetes Care, Inc. (NASDAQ:TNDM)

Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Rating) – Equities research analysts at Oppenheimer dropped their Q2 2022 earnings estimates for Tandem Diabetes Care in a report issued on Thursday, August 4th. Oppenheimer analyst S. Lichtman now anticipates that the medical device company will post earnings of ($0.24) per share for the quarter, down from […]

Illinois
United-states
Kimd-blickenstaff
Davidb-berger
Raymond-james
Tandem-diabetes-care-inc
Illinois-municipal-retirement-fund
Timessquare-capital-management
Tandem-diabetes-care-company-profile
Nasdaq
Securian-asset-management-inc
Tandem-diabetes-care

Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Position Increased by Strs Ohio

Strs Ohio increased its position in Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Rating) by 22.0% during the first quarter, according to its most recent Form 13F filing with the SEC. The fund owned 10,244 shares of the medical device company’s stock after buying an additional 1,847 shares during the period. Strs Ohio’s holdings in […]

United-states
Kimd-blickenstaff
Christopherj-twomey
Piper-sandler
Tandem-diabetes-care-inc
Northwestern-mutual-investment-management-company
Commonwealth-equity-services
Citigroup
Nasdaq
Securian-asset-management-inc
Strs-ohio
Tandem-diabetes-care

Zacks: Brokerages Expect Tandem Diabetes Care, Inc. (NASDAQ:TNDM) Will Post Quarterly Sales of $204.90 Million

Analysts expect Tandem Diabetes Care, Inc. (NASDAQ:TNDM – Get Rating) to announce sales of $204.90 million for the current quarter, according to Zacks. Five analysts have made estimates for Tandem Diabetes Care’s earnings, with the highest sales estimate coming in at $206.50 million and the lowest estimate coming in at $203.82 million. Tandem Diabetes Care […]

United-states
Kimd-blickenstaff
Davidb-berger
Piper-sandler
Tandem-diabetes-care-inc
Zacks-investment-research
Nasdaq
Wells-fargo-company
Ci-investments-inc
Moors-cabot-inc
Byrne-asset-management
Sandy-cove-advisors

vimarsana © 2020. All Rights Reserved.